X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TTK HEALTHCARE - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS TTK HEALTHCARE NOVARTIS/
TTK HEALTHCARE
 
P/E (TTM) x 261.0 36.0 724.1% View Chart
P/BV x 22.2 6.6 335.0% View Chart
Dividend Yield % 1.6 0.4 374.6%  

Financials

 NOVARTIS   TTK HEALTHCARE
EQUITY SHARE DATA
    NOVARTIS
Mar-17
TTK HEALTHCARE
Mar-14
NOVARTIS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs855663 128.9%   
Low Rs666399 166.8%   
Sales per share (Unadj.) Rs219.0535.6 40.9%  
Earnings per share (Unadj.) Rs19.115.9 119.8%  
Cash flow per share (Unadj.) Rs20.320.0 101.4%  
Dividends per share (Unadj.) Rs10.004.00 250.0%  
Dividend yield (eoy) %1.30.8 174.7%  
Book value per share (Unadj.) Rs307.0137.6 223.0%  
Shares outstanding (eoy) m29.967.77 385.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.51.0 350.0%   
Avg P/E ratio x39.833.3 119.5%  
P/CF ratio (eoy) x37.526.5 141.2%  
Price / Book Value ratio x2.53.9 64.2%  
Dividend payout %52.425.1 208.7%   
Avg Mkt Cap Rs m22,7794,127 551.9%   
No. of employees `0000.71.7 39.5%   
Total wages/salary Rs m1,393607 229.6%   
Avg. sales/employee Rs Th9,736.22,436.7 399.6%   
Avg. wages/employee Rs Th2,066.8355.2 581.9%   
Avg. net profit/employee Rs Th849.072.5 1,170.3%   
INCOME DATA
Net Sales Rs m6,5624,162 157.7%  
Other income Rs m70261 1,146.2%   
Total revenues Rs m7,2644,223 172.0%   
Gross profit Rs m259197 131.4%  
Depreciation Rs m3632 113.2%   
Interest Rs m730 24.1%   
Profit before tax Rs m917197 466.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34573 474.0%   
Profit after tax Rs m572124 461.8%  
Gross profit margin %3.94.7 83.3%  
Effective tax rate %37.637.0 101.6%   
Net profit margin %8.73.0 292.9%  
BALANCE SHEET DATA
Current assets Rs m9,7311,629 597.5%   
Current liabilities Rs m1,8301,058 173.0%   
Net working cap to sales %120.413.7 877.7%  
Current ratio x5.31.5 345.3%  
Inventory Days Days4930 163.5%  
Debtors Days Days2534 74.9%  
Net fixed assets Rs m57556 10.3%   
Share capital Rs m14178 181.1%   
"Free" reserves Rs m9,056878 1,031.0%   
Net worth Rs m9,1961,069 860.0%   
Long term debt Rs m0159 0.0%   
Total assets Rs m11,4992,399 479.3%  
Interest coverage x128.47.6 1,694.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.7 32.9%   
Return on assets %5.06.4 78.6%  
Return on equity %6.211.6 53.7%  
Return on capital %10.118.5 54.5%  
Exports to sales %00.8 0.0%   
Imports to sales %01.4 0.0%   
Exports (fob) Rs mNA33 0.0%   
Imports (cif) Rs mNA58 0.0%   
Fx inflow Rs m12933 391.8%   
Fx outflow Rs m1,73463 2,743.9%   
Net fx Rs m-1,605-30 5,298.8%   
CASH FLOW
From Operations Rs m-380127 -299.8%  
From Investments Rs m4,208-146 -2,881.9%  
From Financial Activity Rs m-3,31822 -15,150.7%  
Net Cashflow Rs m5103 20,404.0%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 3.7 54.1%  
FIIs % 1.6 5.2 30.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 25.8 83.3%  
Shareholders   41,647 12,723 327.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 22, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - CIPLA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS